OmniAb, Inc. (OABI)
OABI Stock Price Chart
Explore OmniAb, Inc. interactive price chart. Choose custom timeframes to analyze OABI price movements and trends.
OABI Company Profile
Discover essential business fundamentals and corporate details for OmniAb, Inc. (OABI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Sept 2021
Employees
114.00
Website
https://www.omniab.comCEO
Matthew W. Foehr
Description
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
OABI Financial Timeline
Browse a chronological timeline of OmniAb, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.15.
Earnings released on 6 Aug 2025
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%, while revenue for the quarter reached $3.90M , missing expectations by -30.88%.
Earnings released on 8 May 2025
EPS came in at -$0.17 matching the estimated -$0.17, while revenue for the quarter reached $4.15M , missing expectations by -7.45%.
Earnings released on 18 Mar 2025
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%, while revenue for the quarter reached $10.80M , beating expectations by +65.34%.
Earnings released on 12 Nov 2024
EPS came in at -$0.16 falling short of the estimated -$0.14 by -14.29%, while revenue for the quarter reached $4.17M , missing expectations by -58.81%.
Earnings released on 8 Aug 2024
EPS came in at -$0.13 surpassing the estimated -$0.18 by +27.78%, while revenue for the quarter reached $7.61M , beating expectations by +32.19%.
Earnings released on 9 May 2024
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $3.80M , missing expectations by -35.22%.
Earnings released on 20 Mar 2024
EPS came in at -$0.14 surpassing the estimated -$0.17 by +17.65%, while revenue for the quarter reached $4.82M , missing expectations by -35.38%.
Earnings released on 9 Nov 2023
EPS came in at -$0.16 falling short of the estimated -$0.14 by -14.29%, while revenue for the quarter reached $5.48M , missing expectations by -46.98%.
Earnings released on 10 Aug 2023
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%, while revenue for the quarter reached $6.95M , missing expectations by -41.68%.
Earnings released on 11 May 2023
EPS came in at -$0.06 falling short of the estimated $0.05 by -220.00%, while revenue for the quarter reached $16.92M , missing expectations by -10.84%.
Earnings released on 30 Mar 2023
EPS came in at $0.07 surpassing the estimated $0.02 by +250.00%, while revenue for the quarter reached $35.35M , beating expectations by +26.15%.
Earnings released on 10 Nov 2022
EPS came in at -$0.02 surpassing the estimated -$0.04 by +43.65%, while revenue for the quarter reached $6.91M , meeting expectations.
Earnings released on 12 Aug 2022
EPS came in at -$0.09 , while revenue for the quarter reached $7.20M .
Earnings released on 20 May 2022
EPS came in at -$0.05 , while revenue for the quarter reached $9.62M .
Earnings released on 28 Mar 2022
EPS came in at -$0.00 , while revenue for the quarter reached $6.28M .
Earnings released on 25 Mar 2022
EPS came in at -$0.13 , while revenue for the quarter reached $21.56M .
Earnings released on 30 Jun 2021
EPS came in at -$0.08 , while revenue for the quarter reached $5.59M .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 , while revenue for the quarter reached $6.60M .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 , while revenue for the quarter reached $13.33M .
Earnings released on 30 Sept 2020
EPS came in at -$0.06 , while revenue for the quarter reached $4.99M .
OABI Stock Performance
Access detailed OABI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.